Consolidated Statements of Comprehensive Loss (Unaudited) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Net income/(loss) including noncontrolling interests	$ (3,886,421)	$ (5,906,870)	$ (14,673,569)	$ (12,305,764)
Other comprehensive income (loss)
Foreign currency translation adjustment	(282,622)	(668,874)	(440,069)	65,764
Comprehensive income/(loss) including noncontrolling interests	(4,169,043)	(6,575,744)	(15,113,638)	(12,240,000)
Comprehensive loss attributable to noncontrolling interests	961,118	1,122,633	2,049,198	1,815,293
Comprehensive income/(loss) attributable to Cleveland BioLabs, Inc.	$ (3,207,925)	$ (5,453,111)	$ (13,064,440)	$ (10,424,707)